Statins and prostate cancer recurrence following radical prostatectomy or radiotherapy: a systematic review and meta-analysis
- 31 May 2013
- journal article
- review article
- Published by Elsevier BV in Annals Of Oncology
- Vol. 24 (6), 1427-1434
- https://doi.org/10.1093/annonc/mdt077
Abstract
Background: In this meta-analysis, we evaluated associations between statins and recurrence-free survival (RFS) following treatment of localized prostate cancer, with attention to potential benefits among patients treated primarily with radiotherapy (RT) versus radical prostatectomy. Patients and methods: We identified original studies examining the effect of statins on men who received definitive treatment of localized prostate cancer using a systematic search of the PubMed and EMBASE databases through August 2012. Our search yielded 17 eligible studies from 794 references; 13 studies with hazard ratios (HRs) for RFS were included in the formal meta-analysis. Results: Overall, statins did not affect RFS (HR 0.90, 95% Cl 0.74-1.08). However, in AT patients (six studies), statins were associated with a statistically significant improvement in RFS (HR 0.68; 95% Cl 0.49-0.93); this benefit was not observed in radical prostatectomy patients (seven studies). Sensitivity analyses suggested that primary treatment modality may impact the effect of statins on prostate cancer recurrence. Conclusions: Our meta-analysis suggests a potentially beneficial effect of statins on prostate cancer patients treated with RT but not among radical prostatectomy patients. Although limited by the lack of randomized data, these results suggest that primary treatment modality should be considered in future studies examining associations between statins and oncologic outcomes.Keywords
Funding Information
- NIH
This publication has 62 references indexed in Scilit:
- Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 studyCanadian Urological Association Journal, 2013
- Aspirin and Statin Nonuse Associated With Early Biochemical Failure After Prostate Radiation TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Statins: Is It Really Time to Reassess Benefits and Risks?New England Journal of Medicine, 2012
- Factors Implicated in Radiation Therapy Failure and Radiosensitization of Prostate CancerProstate Cancer, 2011
- Association of Statin Use With Pathological Tumor Characteristics and Prostate Cancer Recurrence After SurgeryJournal of Urology, 2011
- Statin medication use and the risk of biochemical recurrence after radical prostatectomyCancer, 2010
- Practical methods for incorporating summary time-to-event data into meta-analysisTrials, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986